Parabilis Medicines, Inc. (PBLS)
SBC to Revenue
375.69%
TTM · Retrieved:

PBLS SBC to Revenue
What is sbc to revenue?
Stock-based compensation as percentage of revenue.
PBLS sbc to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% |
Frequently asked questions: PBLS sbc to revenue
What is Parabilis Medicines, Inc. (PBLS)'s current sbc to revenue?
Parabilis Medicines, Inc. (PBLS)'s latest reported sbc to revenue (TTM) is 375.69% as of Nov 19, 2026. Stock-based compensation as percentage of revenue.
How much historical sbc to revenue data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s sbc to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's sbc to revenue to peers or set an alert?
You can open PBLS's sbc to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance